Pancreatitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your pancreatitis symptoms started no more than 5 days ago
- Your pancreatitis has been classified as moderate or severe (based on a standard medical grading system called the Atlanta classification)
- A CT scan has confirmed your pancreatitis, and the scan shows a severity score of 4 points or higher on a standard rating scale
- Your overall illness severity score (called APACHE II) is higher than 8 points
- You show signs that your body is under significant stress, either through organ strain or through 2 or more of the following: a fever above 38°C or a very low temperature below 36°C, a heart rate of 90 beats per minute or more, a breathing rate of 20 breaths per minute or more (or low carbon dioxide levels in the blood), or an abnormal white blood cell count (confirm with trial site)
Who may not be able to join:
- Your organ failure score (called SOFA) is higher than 12 points
- You have a surgical infection in your body that is not yet under control
- You have developed signs of a serious blood infection (sepsis)
- Your pancreatitis is a flare-up of a long-term (chronic) pancreatitis condition, rather than a new episode
- Your blood fat (triglyceride) levels are extremely high — above 1000 mg/dL
- You have significant liver scarring (cirrhosis) that scores more than 6 points on a standard liver health scale
- You have a blockage or pressure problem in your bile ducts that has not been treated
- Your Body Mass Index (BMI) is 40 or above
- You have dementia
- You have advanced kidney disease (stage 4 or 5)
- You have recently been diagnosed with a blood clot in the lungs (confirmed by CT scan)
- You had a heart attack within the last 4 weeks
- You have recently had a stroke
- You have severe heart failure
- You have had uncontrolled bleeding or significant blood loss within the last 24 hours
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vladimir Kiselev, PhD, MD, N. V. Sklifosovsky Moscow Research Institute of Emergency
Phone: +79636564765
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
SOFA score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.